Literature DB >> 34021132

Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects.

Jelena Scekic-Zahirovic1, Inmaculada Sanjuan-Ruiz1, Vanessa Kan2,3, Salim Megat1, Pierre De Rossi4, Stéphane Dieterlé1, Raphaelle Cassel1,5, Marguerite Jamet1, Pascal Kessler6, Diana Wiesner7,8, Laura Tzeplaeff5, Valérie Demais9, Sonu Sahadevan4, Katharina M Hembach4, Hans-Peter Muller7, Gina Picchiarelli1, Nibha Mishra10,11, Stefano Antonucci7,8, Sylvie Dirrig-Grosch1, Jan Kassubek7, Volker Rasche12, Albert Ludolph7,8, Anne-Laurence Boutillier5, Francesco Roselli7,8, Magdalini Polymenidou4, Clotilde Lagier-Tourenne10,11, Sabine Liebscher13,14,15, Luc Dupuis16.   

Abstract

Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS lead to severe forms of amyotrophic lateral sclerosis (ALS). Cytoplasmic accumulation of FUS is also observed in other diseases, with unknown consequences. Here, we show that cytoplasmic mislocalization of FUS drives behavioral abnormalities in knock-in mice, including locomotor hyperactivity and alterations in social interactions, in the absence of widespread neuronal loss. Mechanistically, we identified a progressive increase in neuronal activity in the frontal cortex of Fus knock-in mice in vivo, associated with altered synaptic gene expression. Synaptic ultrastructural and morphological defects were more pronounced in inhibitory than excitatory synapses and associated with increased synaptosomal levels of FUS and its RNA targets. Thus, cytoplasmic FUS triggers synaptic deficits, which is leading to increased neuronal activity in frontal cortex and causing related behavioral phenotypes. These results indicate that FUS mislocalization may trigger deleterious phenotypes beyond motor neuron impairment in ALS, likely relevant also for other neurodegenerative diseases characterized by FUS mislocalization.

Entities:  

Year:  2021        PMID: 34021132     DOI: 10.1038/s41467-021-23187-9

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  105 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  Michael A van Es; Orla Hardiman; Adriano Chio; Ammar Al-Chalabi; R Jeroen Pasterkamp; Jan H Veldink; Leonard H van den Berg
Journal:  Lancet       Date:  2017-05-25       Impact factor: 79.321

2.  TDP-43 and FUS: a nuclear affair.

Authors:  Dorothee Dormann; Christian Haass
Journal:  Trends Neurosci       Date:  2011-06-22       Impact factor: 13.837

Review 3.  Amyotrophic Lateral Sclerosis.

Authors:  Robert H Brown; Ammar Al-Chalabi
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

Review 4.  Decoding ALS: from genes to mechanism.

Authors:  J Paul Taylor; Robert H Brown; Don W Cleveland
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

5.  Novel missense and truncating mutations in FUS/TLS in familial ALS.

Authors:  S Waibel; M Neumann; M Rabe; T Meyer; A C Ludolph
Journal:  Neurology       Date:  2010-07-21       Impact factor: 9.910

6.  Truncating mutations in FUS/TLS give rise to a more aggressive ALS-phenotype than missense mutations: a clinico-genetic study in Germany.

Authors:  S Waibel; M Neumann; A Rosenbohm; A Birve; A E Volk; J H Weishaupt; T Meyer; U Müller; P M Andersen; A C Ludolph
Journal:  Eur J Neurol       Date:  2012-12-06       Impact factor: 6.089

7.  Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.

Authors:  T J Kwiatkowski; D A Bosco; A L Leclerc; E Tamrazian; C R Vanderburg; C Russ; A Davis; J Gilchrist; E J Kasarskis; T Munsat; P Valdmanis; G A Rouleau; B A Hosler; P Cortelli; P J de Jong; Y Yoshinaga; J L Haines; M A Pericak-Vance; J Yan; N Ticozzi; T Siddique; D McKenna-Yasek; P C Sapp; H R Horvitz; J E Landers; R H Brown
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

8.  Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.

Authors:  Jelena Scekic-Zahirovic; Oliver Sendscheid; Hajer El Oussini; Mélanie Jambeau; Ying Sun; Sina Mersmann; Marina Wagner; Stéphane Dieterlé; Jérome Sinniger; Sylvie Dirrig-Grosch; Kevin Drenner; Marie-Christine Birling; Jinsong Qiu; Yu Zhou; Hairi Li; Xiang-Dong Fu; Caroline Rouaux; Tatyana Shelkovnikova; Anke Witting; Albert C Ludolph; Friedemann Kiefer; Erik Storkebaum; Clotilde Lagier-Tourenne; Luc Dupuis
Journal:  EMBO J       Date:  2016-03-07       Impact factor: 11.598

9.  Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.

Authors:  Caroline Vance; Boris Rogelj; Tibor Hortobágyi; Kurt J De Vos; Agnes Lumi Nishimura; Jemeen Sreedharan; Xun Hu; Bradley Smith; Deborah Ruddy; Paul Wright; Jeban Ganesalingam; Kelly L Williams; Vineeta Tripathi; Safa Al-Saraj; Ammar Al-Chalabi; P Nigel Leigh; Ian P Blair; Garth Nicholson; Jackie de Belleroche; Jean-Marc Gallo; Christopher C Miller; Christopher E Shaw
Journal:  Science       Date:  2009-02-27       Impact factor: 47.728

Review 10.  Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.

Authors:  Dorothee Dormann; Christian Haass
Journal:  Mol Cell Neurosci       Date:  2013-04-02       Impact factor: 4.314

View more
  3 in total

Review 1.  Emerging Mechanisms Underpinning Neurophysiological Impairments in C9ORF72 Repeat Expansion-Mediated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.

Authors:  Iris-Stefania Pasniceanu; Manpreet Singh Atwal; Cleide Dos Santos Souza; Laura Ferraiuolo; Matthew R Livesey
Journal:  Front Cell Neurosci       Date:  2021-12-15       Impact factor: 5.505

Review 2.  Breakdown of the central synapses in C9orf72-linked ALS/FTD.

Authors:  Layla T Ghaffari; Davide Trotti; Aaron R Haeusler; Brigid K Jensen
Journal:  Front Mol Neurosci       Date:  2022-09-16       Impact factor: 6.261

Review 3.  Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?

Authors:  Jeremy S Lum; Justin J Yerbury
Journal:  Front Mol Neurosci       Date:  2022-09-09       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.